Neurogene Inc. Operating Cash Flow
Neurogene Inc. (NGNE) reported Operating Cash Flow of -$49.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- Neurogene Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$23.76M.
- Neurogene Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$26.12M.
- Neurogene Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$17.43M.
- Neurogene Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$19.51M.
- Neurogene Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$77.17M.
- Neurogene Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$70.60M.
- Neurogene Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$51.42M.
- Neurogene Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$52.82M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$23.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$49.88M 10-Q · filed 2026-08-11 | -$67.31M derived: sum of 3 quarters · filed 2026-08-11 | -$86.82M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$26.12M 10-Q · filed 2026-05-12 | -$43.55M derived: sum of 2 quarters · filed 2026-05-12 | -$63.06M derived: sum of 3 quarters · filed 2026-05-12 | -$82.52M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$17.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$36.94M derived: sum of 2 quarters · filed 2026-03-24 | -$56.40M derived: sum of 3 quarters · filed 2026-08-11 | -$77.17M 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | -$19.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$38.97M derived: sum of 2 quarters · filed 2026-08-11 | -$59.74M 10-Q · filed 2025-11-13 | -$77.24M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | -$19.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$40.24M 10-Q · filed 2026-08-11 | -$57.73M derived: sum of 3 quarters · filed 2026-08-11 | -$73.30M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | -$20.77M 10-Q · filed 2026-05-12 | -$38.27M derived: sum of 2 quarters · filed 2026-05-12 | -$53.83M derived: sum of 3 quarters · filed 2026-05-12 | -$69.73M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$17.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$33.06M derived: sum of 2 quarters · filed 2026-03-24 | -$48.95M derived: sum of 3 quarters · filed 2026-03-24 | -$70.60M 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | -$15.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$31.46M derived: sum of 2 quarters · filed 2025-11-13 | -$53.11M 10-Q · filed 2025-11-13 | -$70.08M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$15.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$37.54M 10-Q · filed 2025-08-11 | -$54.52M derived: sum of 3 quarters · filed 2025-08-11 | -$66.08M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | -$21.65M 10-Q · filed 2025-05-09 | -$38.62M derived: sum of 2 quarters · filed 2025-05-09 | -$50.19M derived: sum of 3 quarters · filed 2025-05-09 | -$59.52M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | -$16.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$28.54M derived: sum of 2 quarters · filed 2025-03-24 | -$37.87M derived: sum of 3 quarters · filed 2025-03-24 | -$51.42M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | -$11.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | -$20.89M derived: sum of 2 quarters · filed 2024-11-18 | -$34.45M 10-Q · filed 2024-11-18 | -$21.35M 10-Q · filed 2023-11-14 | -$52.60M derived: sum of 4 quarters · filed 2024-11-18 | |||
| 2023-06-30 | -$9.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$22.88M 10-Q · filed 2024-08-09 | -$17.08M 10-Q · filed 2023-08-10 | -$41.03M derived: sum of 3 quarters · filed 2024-08-09 | -$50.32M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | -$13.55M 10-Q · filed 2024-05-10 | -$13.03M 10-Q · filed 2023-05-08 | -$31.70M derived: sum of 2 quarters · filed 2024-05-10 | -$40.99M derived: sum of 3 quarters · filed 2024-05-10 | -$52.29M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | -$18.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$27.44M derived: sum of 2 quarters · filed 2024-03-18 | -$38.73M derived: sum of 3 quarters · filed 2024-03-18 | -$52.82M 10-K · filed 2024-03-18 | -$45.61M 10-K · filed 2023-03-20 | |||
| 2022-09-30 | -$9.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$20.58M derived: sum of 2 quarters · filed 2023-11-14 | -$34.67M 10-Q · filed 2023-11-14 | -$46.84M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$11.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$25.39M 10-Q · filed 2023-08-10 | -$37.55M derived: sum of 3 quarters · filed 2023-08-10 | -$46.31M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$14.09M 10-Q · filed 2023-05-08 | -$26.26M derived: sum of 2 quarters · filed 2023-05-08 | -$35.02M derived: sum of 3 quarters · filed 2023-05-08 | -$48.29M derived: sum of 4 quarters · filed 2023-05-08 | ||||
| 2021-12-31 | -$12.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$20.92M derived: sum of 2 quarters · filed 2023-03-20 | -$34.20M derived: sum of 3 quarters · filed 2023-03-20 | -$47.56M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$8.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$22.03M derived: sum of 2 quarters · filed 2022-11-14 | -$35.39M 10-Q · filed 2022-11-14 | -$44.62M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$13.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$26.63M 10-Q · filed 2022-08-09 | -$35.86M derived: sum of 3 quarters · filed 2022-08-09 | -$35.98M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$13.36M 10-Q · filed 2022-05-09 | -$22.59M derived: sum of 2 quarters · filed 2022-05-09 | -$22.70M derived: sum of 3 quarters · filed 2022-05-09 | -$31.49M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | -$9.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$9.34M derived: sum of 2 quarters · filed 2022-03-01 | -$18.14M derived: sum of 3 quarters · filed 2022-03-01 | -$24.57M 10-K · filed 2022-03-01 | ||||
| 2020-09-30 | -$112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$8.91M derived: sum of 2 quarters · filed 2021-11-04 | -$15.35M 10-Q · filed 2021-11-04 | -$19.98M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$8.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$15.23M 10-Q · filed 2021-08-05 | -$19.87M derived: sum of 3 quarters · filed 2021-08-05 | -$26.40M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$6.44M 10-Q · filed 2021-05-12 | -$11.08M derived: sum of 2 quarters · filed 2021-05-12 | -$17.61M derived: sum of 3 quarters · filed 2021-05-12 | -$19.08M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | -$4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$11.17M derived: sum of 2 quarters · filed 2021-03-25 | -$12.64M derived: sum of 3 quarters · filed 2021-03-25 | -$15.39M 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | -$6.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$8.00M derived: sum of 2 quarters · filed 2020-11-09 | -$10.76M 10-Q · filed 2020-11-09 | -$20.53M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$4.23M 10-Q · filed 2020-08-12 | -$14.00M derived: sum of 3 quarters · filed 2020-08-12 | -$29.39M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | -$2.76M 10-Q · filed 2020-05-06 | -$12.53M derived: sum of 2 quarters · filed 2020-05-06 | -$27.93M derived: sum of 3 quarters · filed 2020-05-06 | -$18.74M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | -$9.78M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$25.17M derived: sum of 2 quarters · filed 2020-03-12 | -$15.99M derived: sum of 3 quarters · filed 2020-03-12 | -$31.58M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | -$15.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$6.21M derived: sum of 2 quarters · filed 2019-11-13 | -$21.80M 10-Q · filed 2019-11-13 | -$33.41M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $9.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$6.41M 10-Q · filed 2019-08-01 | -$18.01M derived: sum of 3 quarters · filed 2020-03-12 | -$29.54M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | -$15.59M 10-Q · filed 2019-05-07 | -$27.19M derived: sum of 2 quarters · filed 2020-03-12 | -$38.72M derived: sum of 3 quarters · filed 2020-03-12 | -$49.03M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | -$11.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$23.14M derived: sum of 2 quarters · filed 2020-03-12 | -$33.44M derived: sum of 3 quarters · filed 2020-03-12 | -$44.72M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$11.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$21.83M derived: sum of 2 quarters · filed 2018-11-07 | -$33.11M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | -$10.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$21.58M 10-Q · filed 2018-08-08 | ||||||
| 2017-03-31 | -$11.28M 10-Q · filed 2018-05-08 | |||||||
| 2016-12-31 | -$30.23M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |